CVE-2017-17678

  1. OpenCVE
  2. Vulnerabilities (CVE)
  3. CVE-2017-17678
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

6.1 /10

CVSS v3 : MEDIUM

V3 Legend

Vector :

Exploitability : 2.8 / Impact : 2.7

Attack Vector NETWORK

Attack Complexity LOW

Privileges Required NONE

User Interaction REQUIRED

Confidentiality Impact LOW

Integrity Impact LOW

Availability Impact NONE

Scope CHANGED

4.3 /10

CVSS v2.0 : MEDIUM

V2 Legend

Vector : AV:N/AC:M/Au:N/C:N/I:P/A:N

Exploitability : 8.6 / Impact : 2.9

Access Vector NETWORK

Access Complexity MEDIUM

Authentication NONE

Confidentiality Impact NONE

Integrity Impact PARTIAL

Availability Impact NONE

References
Link Resource
http://bmc.com Product
http://remedy.com Product
https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html Release Notes Vendor Advisory
https://seclists.org/fulldisclosure/2017/Oct/52 Mailing List Third Party Advisory
http://bmc.com Product
http://remedy.com Product
https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html Release Notes Vendor Advisory
https://seclists.org/fulldisclosure/2017/Oct/52 Mailing List Third Party Advisory
Configurations

Configuration 1 (hide)

cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*
History

21 Nov 2024, 03:18

Type Values Removed Values Added
References () http://bmc.com - Product () http://bmc.com - Product
References () http://remedy.com - Product () http://remedy.com - Product
References () https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html - Release Notes, Vendor Advisory () https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html - Release Notes, Vendor Advisory
References () https://seclists.org/fulldisclosure/2017/Oct/52 - Mailing List, Third Party Advisory () https://seclists.org/fulldisclosure/2017/Oct/52 - Mailing List, Third Party Advisory

01 Jun 2021, 17:14

Type Values Removed Values Added
CPE cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*
References (MISC) http://remedy.com - (MISC) http://remedy.com - Product
References (MISC) https://seclists.org/fulldisclosure/2017/Oct/52 - (MISC) https://seclists.org/fulldisclosure/2017/Oct/52 - Mailing List, Third Party Advisory
References (MISC) https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html - (MISC) https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html - Release Notes, Vendor Advisory
References (MISC) http://bmc.com - (MISC) http://bmc.com - Product
CWE CWE-79
CVSS v2 : unknown
v3 : unknown 		v2 : 4.3
v3 : 6.1

19 May 2021, 14:15

Type Values Removed Values Added
New CVE
Information

Published : 2021-05-19 14:15

Updated : 2024-11-21 03:18

NVD link : CVE-2017-17678

Mitre link : CVE-2017-17678

CVE.ORG link : CVE-2017-17678

JSON object : View

Products Affected

bmc

  • remedy_mid-tier
CWE
CWE-79

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')